239 related articles for article (PubMed ID: 8538712)
1. Acellular pertussis vaccines for infants.
Edwards KM; Decker MD
N Engl J Med; 1996 Feb; 334(6):391-2. PubMed ID: 8538712
[No Abstract] [Full Text] [Related]
2. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of a pertussis-toxoid vaccine.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccines.
Poltera AA
N Engl J Med; 1996 Jun; 334(23):1547; author reply 1547-8. PubMed ID: 8618620
[No Abstract] [Full Text] [Related]
6. Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II.
Heijbel H; Rasmussen F; Olin P
Dev Biol Stand; 1997; 89():99-100. PubMed ID: 9272337
[No Abstract] [Full Text] [Related]
7. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
8. [Formation of whooping cough antibodies and immunoglobulins in children during immunization with combined pertussis-diphtheria-tetanus vaccine].
Sokolovskaia AD; Zakharova MS; Shavrova EN; Shepsoval EIu; Usviat AZ
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):88-91. PubMed ID: 204136
[No Abstract] [Full Text] [Related]
9. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
[TBL] [Abstract][Full Text] [Related]
10. The Gothenburg pertussis vaccine study.
Trollfors B; Taranger J
Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
[No Abstract] [Full Text] [Related]
11. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
12. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
[No Abstract] [Full Text] [Related]
13. A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.
Stehr K; Cherry JD
Dev Biol Stand; 1997; 89():58-62. PubMed ID: 9333571
[No Abstract] [Full Text] [Related]
14. Efficacy trial of acellular pertussis vaccines; trial I.
Olin P
Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
[No Abstract] [Full Text] [Related]
15. Problems in preparation, testing and use of diphtheria, pertussis and tetanus vaccines.
Banker DD
Prog Drug Res; 1975; 19():229-40. PubMed ID: 1219883
[No Abstract] [Full Text] [Related]
16. Results with a new DTP vaccine in Japan.
Kimura M; Hikino N
Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
[TBL] [Abstract][Full Text] [Related]
17. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
18. Experiences with a new combined vaccine against B. parapertussis, Diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10.
Burianová-Vysoká B; Burian V; Kríz B; Pellar T; Hellerová J; Rádkovský J
Prog Immunobiol Stand; 1967; 3():335-40. PubMed ID: 4314432
[No Abstract] [Full Text] [Related]
19. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
Tapiainen T; Cherry JD; Heininger U
Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
[TBL] [Abstract][Full Text] [Related]
20. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
